“…The chirality of iminosugars demonstrated an important role in their pharmacological properties against carbohydrate-processing enzymes, including NLGase, especially in terms of enzymatic selectivity [45,96,177,178]. In this context, De Fenza et al explored the inhibition potential of L-glucoconfigured N-alkyl-deoxyiminosugars, ent- (4,14,16,91,92) (Figure 22) against NLGase, thereby studying the effect of chirality on the anti-inflammatory treatment of CF [179]. The synthesis of L-DNJ derivatives was achieved exploiting a de novo methodology [180][181][182] that relied on the use of a homologating agent 93 [183][184][185].…”